Guizhou Yibai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Guizhou Yibai Pharmaceutical has a total shareholder equity of CN¥3.1B and total debt of CN¥955.8M, which brings its debt-to-equity ratio to 30.5%. Its total assets and total liabilities are CN¥4.7B and CN¥1.6B respectively. Guizhou Yibai Pharmaceutical's EBIT is CN¥48.2M making its interest coverage ratio 2.1. It has cash and short-term investments of CN¥770.6M.
Key information
30.5%
Debt to equity ratio
CN¥955.78m
Debt
Interest coverage ratio | 2.1x |
Cash | CN¥770.60m |
Equity | CN¥3.13b |
Total liabilities | CN¥1.58b |
Total assets | CN¥4.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600594's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 600594's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥502.8M).
Debt to Equity History and Analysis
Debt Level: 600594's net debt to equity ratio (5.9%) is considered satisfactory.
Reducing Debt: 600594's debt to equity ratio has reduced from 36.4% to 30.5% over the past 5 years.
Debt Coverage: 600594's debt is well covered by operating cash flow (43.4%).
Interest Coverage: 600594's interest payments on its debt are not well covered by EBIT (2.1x coverage).